Yhojan Rodriguez
Overview
Explore the profile of Yhojan Rodriguez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Celis-Andrade M, Rojas M, Rodriguez Y, Calderon J, Rodriguez-Jimenez M, Monsalve D, et al.
Clin Rheumatol
. 2024 Sep;
43(11):3313-3322.
PMID: 39243279
Objective: To evaluate the performance of the Systemic Lupus Erythematosus Risk Probability Index (SLERPI) in Colombian patients with systemic lupus erythematosus (SLE). Methods: The Colombian cohort included 435 SLE patients...
2.
Celis-Andrade M, Morales-Gonzalez V, Rojas M, Monsalve D, Acosta-Ampudia Y, Rodriguez-Jimenez M, et al.
Diabetes Metab Syndr
. 2024 Jul;
18(7):103087.
PMID: 39074403
Background: Patients afflicted by type 1 diabetes (T1D) exhibit polyautoimmunity (PolyA). However, the frequency and distribution of PolyA in T1D is still unknown. Objective: We conducted a systematic review and...
3.
Camacho-Dominguez L, Rojas M, Herran M, Rodriguez Y, Beltran S, Galindo P, et al.
BMJ Open
. 2024 Feb;
14(2):e072784.
PMID: 38355186
Background: A paucity of predictive models assessing risk factors for COVID-19 mortality that extend beyond age and gender in Latino population is evident in the current academic literature. Objectives: To...
4.
Morales-Gonzalez V, Galeano-Sanchez D, Covaleda-Vargas J, Rodriguez Y, Monsalve D, Pardo-Rodriguez D, et al.
Front Mol Biosci
. 2023 Aug;
10:1215039.
PMID: 37614441
Systemic sclerosis (SSc) is a chronic autoimmune disease, marked by an unpredictable course, high morbidity, and increased mortality risk that occurs especially in the diffuse and rapidly progressive forms of...
5.
Rodriguez Y, Rojas M, Beltran S, Polo F, Camacho-Dominguez L, Morales S, et al.
J Autoimmun
. 2022 Aug;
132:102898.
PMID: 36041291
Autoimmunity linked to COVID-19 immunization has been recorded throughout the pandemic. Herein we present six new patients who experienced relapses of previous autoimmune disease (AD) or developed a new autoimmune...
6.
Rojas M, Rodriguez Y, Hernandez J, Diaz-Coronado J, Daza Vergara J, Velez V, et al.
BMC Infect Dis
. 2022 Jun;
22(1):575.
PMID: 35761219
Background: Convalescent plasma (CP) has been widely used to treat COVID-19 and is under study. However, the variability in the current clinical trials has averted its wide use in the...
7.
Rojas M, Rodriguez Y, Acosta-Ampudia Y, Monsalve D, Zhu C, Li Q, et al.
J Transl Med
. 2022 Mar;
20(1):129.
PMID: 35296346
Autoimmunity has emerged as a characteristic of the post-COVID syndrome (PCS), which may be related to sex. In order to further investigate the relationship between SARS-CoV-2 and autoimmunity in PCS,...
8.
Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome
Acosta-Ampudia Y, Monsalve D, Rojas M, Rodriguez Y, Zapata E, Ramirez-Santana C, et al.
J Infect Dis
. 2022 Jan;
225(12):2155-2162.
PMID: 35079804
Background: The immunopathological pathways enabling post-coronavirus disease 2019 (COVID-19) syndrome (PCS) development are not entirely known. We underwent a longitudinal analysis of patients with COVID-19 who developed PCS aiming to...
9.
Camacho-Dominguez L, Rodriguez Y, Polo F, Restrepo Gutierrez J, Zapata E, Rojas M, et al.
J Transl Autoimmun
. 2022 Jan;
5:100140.
PMID: 35013724
Autoimmunity following COVID-19 vaccination has been reported. Herein, a 79-year-old man with clinical and immunological features of autoimmune hepatitis type 1 after ChAdOx1 nCoV-19 vaccination is presented. Clinical manifestations rapidly...
10.
Rojas M, Ramirez-Santana C, Acosta-Ampudia Y, Monsalve D, Rodriguez-Jimenez M, Zapata E, et al.
J Autoimmun
. 2021 Dec;
126:102780.
PMID: 34923432
Objective: The clinical coexistence of two or more autoimmune diseases (ADs) fulfilling classification criteria is termed "overt polyautoimmunity" (PolyA), whereas the presence of autoantibodies unrelated to an index AD, without...